Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2007
09/20/2007US20070220620 TAT-046 and methods of assessing and treating cancer
09/20/2007US20070219767 Atomic coordinates of albumin drug complexes and method of use of pharmaceutical development
09/20/2007US20070219729 System for the Evaluation of Tracer Concentration in a Reference Tissue and a Target Region
09/20/2007US20070219574 Method and apparatus for a multi-use body fluid sampling device with analyte sensing
09/20/2007US20070219463 Methods and apparatus for lancet actuation
09/20/2007US20070219462 Methods and apparatus for lancet actuation
09/20/2007US20070219354 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity
09/20/2007US20070219351 Conjugating doxorubicin (6-maleimidocaproyl)hydrazone with lactosaminated albumin in the presence of tris(2-carboxyethyl)phosphine reducing agent
09/20/2007US20070219347 Meningitidis B serogroup; amino acid sequence encoded by nucleotides 564043 to 565882 of sequence 1; monoclonal antibodies; vaccine antigens
09/20/2007US20070219134 Lymphatic zip codes in tumors and pre-malignant lesions
09/20/2007US20070219130 Administering an effective amount of a SLURP-1 polypeptide of SEQ ID NO: 2; analegsics; neuregulins, promoting the the amplitude of acetylcholine-evoked macroscopic currents; nervous system disorders; neuroprotectants; skindisorders
09/20/2007US20070218610 Methods of making a molecular detection chip having a metal oxide silicon field effect transistor on sidewalls of a micro-fluid channel
09/20/2007US20070218567 Sensing method for biopolymers and sensing device therefor
09/20/2007US20070218566 Method and Device for Improved Purification of a Substance Bound to Paramagnetic Microparticles
09/20/2007US20070218565 using a human Fc epsilon receptor (Fc68 R) to detect epsilon immunoglobulin (IgE); detecting a plant allergy in a canid, felid or equid
09/20/2007US20070218562 Color indicator for halamine treated fabric
09/20/2007US20070218561 Analysis of amino acids in body fluid by liquid chromatography-mass spectrometry
09/20/2007US20070218560 Isobaric sets, mass differential labeling sets; mass spectrometry
09/20/2007US20070218559 Method for performing a non-invasive blood gas test
09/20/2007US20070218558 Uncoated membrane; may include white blood cell, platelet and reticulocyte component; use in analyzers
09/20/2007US20070218557 Test Element and Method for Testing Blood
09/20/2007US20070218556 Measuring nutrients in plants and soils by laser induced breakdown spectroscopy
09/20/2007US20070218520 identifying and measuring the effect that an agent has upon modulating the binding of a test compound to a GPCR
09/20/2007US20070218519 Diabetes-associated markers and methods of use thereof
09/20/2007US20070218518 identifying a compound which interferes with the binding of Tir (translocated intimin receptor) polypeptide to intimin; vaccine
09/20/2007US20070218517 Methods for Comparing the Immunogenicity of Products and Uses Thereof
09/20/2007US20070218516 Recombinant chimeric human anti-botulinum antibodies
09/20/2007US20070218515 Method and kits for the determination of the antigens on the red blood cells and antibodies of serum
09/20/2007US20070218514 Diagnostic methods relating to Graves' disease and other autoimmune disorders
09/20/2007US20070218513 Differentially Expressed Genes Related to Coronary Artery Disease
09/20/2007US20070218512 Methods related to mmp26 status as a diagnostic and prognostic tool in cancer management
09/20/2007US20070218511 Methods for the diagnosis and treatment of lung cancer
09/20/2007US20070218510 Use of protein PSA3 as a marker for colorectal cancer
09/20/2007US20070218509 Murine Living Tissue Model & UsesTthereof
09/20/2007US20070218508 Detection and amplification of ligands
09/20/2007US20070218507 Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them
09/20/2007US20070218506 Immunoassays for Buprenorphine and Norbuprenorphine
09/20/2007US20070218505 Identification of biomolecules through expression patterns in mass spectrometry
09/20/2007US20070218504 Human leptin-derived polypeptides and uses thereof
09/20/2007US20070218503 Methods of polypeptide identification, and compositions therefor
09/20/2007US20070218502 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation
09/20/2007US20070218501 Assays to predict atherosclerosis and dysfunctional high-density lipoprotein
09/20/2007US20070218500 Method and Apparatus for Detection of Live Bacterium Within Test Subject Through Specifically labeling Thereof
09/20/2007US20070218499 Monoclonal Antibodies That Target Pathological Assemblies Of Amyloid B (Abeta)
09/20/2007US20070218498 Use of soluble FLT-1 and its fragments in cardiovascular conditions
09/20/2007US20070218497 Quick Test for the Diagnosis of Alzheimer's Disease
09/20/2007US20070218493 Diagnostic marker for interferon responsiveness in multiple sclerosis
09/20/2007US20070218491 Oligomerization of amyloid proteins
09/20/2007US20070218484 Feature Quality in Array Fabrication
09/20/2007US20070218466 screening assay to identify agents having antiviral activity against a DNA virus by assessing the effect of a candidate agent upon alternative splicing of MxA
09/20/2007US20070218463 Rearranged squamous cell carcinoma antigen genes II
09/20/2007US20070218462 Method of Predicting a Benefit of Antioxidant Therapy for Prevention of Cardiovascular Disease in Hiperglycemic Patients
09/20/2007US20070218460 Method of Estimating Toxicity of Drug
09/20/2007US20070218453 Sensing Tool
09/20/2007US20070218206 printing onto the substrate at least one time temperature indicator with chromic properties based on an azo coupling reaction between a capped diazonium component and a coupling component
09/20/2007US20070218174 Method of Measuring Calorie of Object and Device of Measuring Calorie of Object
09/20/2007US20070218166 Test Kit and Method for the Determination of Nitrogen Components in Wine
09/20/2007US20070218082 P153 and p156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof
09/20/2007US20070218071 Novel therapeutic targets in cancer
09/20/2007US20070218070 Methods of modulation of the immune system
09/20/2007US20070218069 antibodies that specifically binds ubiquitin comprising a lysine linkage between a lysine residue of one ubiquitin molecule and the C-terminal glycine residue of another ubiquitin molecule
09/20/2007US20070218065 Antibodies that bind both il-17a and il-17f and methods of using the same
09/20/2007US20070218059 Cell Surface Marker
09/20/2007US20070218057 Human Obesity Susceptibility Gene and Uses Thereof
09/20/2007US20070218056 Methods for identification, diagnosis, and treatment of breast cancer
09/20/2007US20070218054 In Vitro germinal centers
09/20/2007US20070218048 Sfec, a Sperm Flagellar Energy Carrier Protein
09/20/2007US20070218047 Diagnostics and Therapeutics for Diseases Associated with Kallikrein 2 (KLK2)
09/20/2007US20070218032 B7-h4 expression on tumor vasculature
09/20/2007US20070218031 Candidate drug which inhibits the interaction between AICD and p53 in neurons is selected as a drug for the prevention and/or treatment of Alzheimer's disease; provides treatment of Alzheimer's disease based on a different Alzheimer's disease onset mechanism from the amyloid hypothesis
09/20/2007US20070218026 DNA encoding the human serine protease EOS
09/20/2007US20070218008 Methods of screening agents, conjugates or conjugate moieties for the ability to enter the CNS by crossing the blood brain barrier in order to treat or diagnose conditions within the CNS; methods entail providing a cell expressing SVCT2 transporter, transporter being situated in plasma membrane of cell
09/20/2007US20070218005 Nuclei density and nuclei area methods for determining the effects of a botulinum toxin on muscles
09/20/2007US20070218003 Truncated Dance, Dance Complex And Method Of Using These
09/20/2007US20070218002 Method for Detecting Alzheimer's Disease and other Forms of Dementia, and Measuring Their Progression
09/20/2007US20070218001 Biotherapeutics, Diagnostics and Research Reagents
09/20/2007US20070218000 component of outer membrane preparations of Neisseria meningitidis capable of inducing bactericidal activity; formulations with the ability to increase the protective spectrum of existing vaccines and hence expanding it against different pathogens
09/20/2007US20070217999 Excretable Reporter Systems
09/20/2007US20070217997 comprising heavy chain and light chain immunoglobulin variable domain sequences; (complementary determining regions) CDR/antibodies, used to treat or prevent metastasis, hyperproliferation, inflammation and disorders characterized by excessive extracellular matrix degradation; enzyme inhibitors
09/20/2007US20070217949 Quality control system
09/20/2007US20070215815 Fluorescence Correlation Spectroscopy with Single Excitation Wavelength
09/20/2007US20070215809 Microfluidic preconditioning of (bio)fluids for reagent-free infrared clinical analysis and diagnostics
09/20/2007US20070215534 Method of purifying polypeptides by simulated moving bed chromatography
09/20/2007US20070215466 Nucleic acid detection device and nucleic acid detection apparatus
09/20/2007US20070215465 Biosensor membrane and methods related thereto
09/20/2007US20070215046 Method for Determining the Gas Permeability of Container Walls, Container Provided with a Surface Coating, and Coating Device Comprising a Measuring Element
09/20/2007US20070214873 Turbidity Sensor
09/20/2007US20070214867 Porous Hybrid Organic-Inorganic Materials for the Detection of Halogens
09/20/2007US20070214862 System and method for improving performance of a fluid sensor for an internal combustion engine
09/20/2007US20070214609 A method and an installation for determining characteristics representive of a physical and/or chemical transformation occuring in a microreactor
09/20/2007DE4293865B4 Verbesserte Cytozentrifugiereinrichtung, Apparatur und Verfahren Improved Cytozentrifugiereinrichtung, apparatus and method
09/20/2007DE202007007706U1 Messvorrichtung zum quantitativen fotometrischen Nachweis von Biomolekülen im Low Density Bereich (Low-Density-Biochips) Measuring device for the quantitative photometric detection of biomolecules in low-density region (low-density biochip)
09/20/2007DE202006012071U1 Vorrichtung zur optischen Untersuchung eines biologischen Gewebes An apparatus for optical examination of biological tissue
09/20/2007DE202006007867U1 Probengefäß Sample vessel
09/20/2007DE10230328B4 Probenträger für Massenspektrometrie Sample support for Mass Spectrometry
09/20/2007DE102007013203A1 Water purification device for softening, decarbonization or demineralization of water, comprises housing, water inlet and outlet lines connectable with external water pipeline, a sensor element, and replaceable/rechargeable energy storage
09/20/2007DE102007012056A1 System und Verfahren zum Verbessern von Leistung eines Fluidsensors für einen Verbrennungsmotor System and method for improving performance of a fluid sensor for a combustion engine
09/20/2007DE102006032394A1 Method for diagnosing, differentiating and characterizing prostate cancer and/or its cell in an biological sample comprises analyzing the expression of cancer cell by at least two markers e.g. a-methacyl-coA racemace and hepsin
09/20/2007DE102006012885A1 Diagnostisches Testsystem zum simultanen, quantitativen Nachweis von HIV1 und HIV2 Antikörpern und/oder HIV Antigenen in humanem Probenmaterial Diagnostic test system for the simultaneous, quantitative detection of HIV1 and HIV2 antibodies and / or HIV antigens in human specimens
09/20/2007DE102006012171A1 Procedure for the determination of neuroendocrinal health disorders such as e.g. chronic fatigue syndrome, comprises measuring glucocorticoids, sex steroids and amino acids/neurotransmitter and/or their metabolites in body fluids